Literature DB >> 11360038

Establishment of enzyme immunoassay for measuring serum sultopride levels.

T Someya1, K Shimoda, T Muratake, E Nakajima, A Shirai, H Funaoka, T Yashiki, H Ishii, N Sunahara, S Takahashi.   

Abstract

Measurement of serum sultopride levels was performed using an enzyme immunoassay. Little or no cross-reactivity with metabolites of sultopride and other drugs was found. The results of reproducibility, recovery, and dilution testing were all good enough for clinical use. A comparison between the measurement values of this method (y) with that of high-performance liquid chromatography (x) showed high correlation (n = 211, r = 0.991, p < 0.0001, y = 0.99x + 107.5). In a comparison between the sultopride dose and serum levels in 161 patients, interindividual differences were large (19 times for same doses), implying that the serum level cannot be predicted from the dosage. The method was found to be reliable for serum level measurements of sultopride and useful for monitoring compliance and assessing the optimal dose.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360038     DOI: 10.1097/00007691-200106000-00016

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  1 in total

1.  Development and validation of amisulpride in human plasma by HPLC coupled with tandem mass spectrometry and its application to a pharmacokinetic study.

Authors:  Ramakotaiah Mogili; Kanchanamala Kanala; Balasekhara Reddy Challa; Babu Rao Chandu; Chandrasekhar Kottapalli Bannoth
Journal:  Sci Pharm       Date:  2011-07-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.